Ribonucleic Acid (RNA) Extraction Machine Market Global Report 2026

The ribonucleic acid (RNA) extraction machine market size has grown rapidly in recent years. It will grow from $1.34 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to rising adoption of molecular diagnostics in clinical laboratories, expansion of genomic and transcriptomic research activities, increasing prevalence of infectious and genetic diseases, growth in pharmaceutical and biotechnology r&d investments, standardization of automated laboratory workflows for nucleic acid extraction.

The ribonucleic acid (RNA) extraction machine market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for precision medicine and personalized healthcare solutions, expansion of next generation sequencing based applications, rising automation in laboratory sample preparation workflows, growth of decentralized and point of care diagnostic systems, increasing investments in biotechnology infrastructure and genomic research ecosystems. Major trends in the forecast period include AI integrated automated rna extraction systems enabling high precision and reduced manual errors, fully automated high throughput extraction platforms supporting large scale genomic workflows, magnetic bead based extraction technologies improving yield and purity of nucleic acids, cartridge based closed system extraction machines enhancing contamination free processing, cloud connected laboratory extraction systems enabling remote monitoring and workflow optimization.

The rising prevalence of infectious diseases is expected to propel the growth of the ribonucleic acid (RNA) extraction machine market going forward. Infectious diseases are illnesses caused by the invasion and multiplication of harmful microorganisms, including viruses, bacteria, fungi, or parasites, within the human body. The increase in infectious diseases is driven by rapid urbanization, as densely populated urban environments facilitate the transmission of contagious illnesses through close human interaction. RNA extraction machines support infectious disease management by enabling automated RNA isolation, high-throughput sample processing, and accurate molecular diagnostic workflows. For instance, in May 2026, according to the UK Health Security Agency, a UK-based government agency, between 1 January and 25 May 2026, England reported 630 laboratory-confirmed measles cases, an increase of 88 cases compared with the previous report published on 11 May 2026. Therefore, the rising prevalence of infectious diseases is driving the growth of the ribonucleic acid (RNA) extraction machine market.

The expansion of personalized medicine is expected to propel the growth of the ribonucleic acid (RNA) extraction machine market going forward. Personalized medicine refers to a healthcare approach that customizes medical treatments based on an individual’s genetic, molecular, and biomarker characteristics to enhance therapeutic outcomes and disease management. The growth of personalized medicine is fueled by advances in genomic sequencing technologies, which have made genetic testing faster, more accessible, and cost-effective for supporting targeted therapies and individualized treatment strategies. RNA extraction machines play a vital role in personalized medicine by isolating high-quality RNA from patient samples, enabling accurate gene expression analysis for biomarker discovery and informed treatment selection. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six approvals in 2022. Therefore, the expansion of personalized medicine is driving the growth of the ribonucleic acid (RNA) extraction machine market.

Major companies operating in the ribonucleic acid (RNA) extraction machine market are concentrating on developing advanced automated sample processing platforms to enhance nucleic acid purification efficiency, increase processing capacity, and minimize manual laboratory effort. Automated sample processing platforms are integrated systems designed to streamline the extraction and purification of RNA and DNA from biological samples with minimal human intervention, ensuring consistent and reliable outcomes. For instance, in January 2023, QIAGEN, a Netherlands-based provider of sample and assay technologies, launched the EZ2 Connect MDx platform for diagnostic laboratories. The automated platform enables the parallel purification of RNA and DNA from up to 24 samples in as little as 30 minutes using magnetic bead technology. It features prefilled reagent cartridges, onboard pipetting, heating capabilities, UV decontamination, and digital connectivity to improve workflow efficiency, operational safety, and laboratory automation for molecular diagnostic applications.

Major companies operating in the ribonucleic acid (RNA) extraction machine market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity, QIAGEN N.V., Promega Corporation, Analytik Jena GmbH+Co. KG, Bioneer Corporation, Tiangen Biotech (Beijing) Co. Ltd., Hamilton Company, Tecan Group Ltd., Beckman Coulter, LGC Biosearch Technologies.

North America was the dominating region in the ribonucleic acid (RNA) extraction machine market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) extraction machine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) extraction machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.